Lysoflam Forte Tablet contains Trypsin Chymotrypsin (100000 AU), a proteolytic enzyme combination used primarily for its anti-inflammatory, anti-edematous, and fibrinolytic properties. This medication is indicated for the management of acute and chronic inflammatory conditions, including post-traumatic swelling, postoperative edema, and soft tissue injuries such as sprains, strains, and contusions. Trypsin and chymotrypsin act by breaking down proteins involved in the inflammatory process, thereby reducing tissue swelling, promoting the resolution of hematomas, and facilitating faster healing. Lysoflam Forte is also utilized in the treatment of conditions associated with excessive fibrin deposition, aiding in the restoration of normal tissue architecture. The enzyme activity of 100000 AU ensures effective therapeutic action while maintaining a favorable safety profile. It is generally well-tolerated, with minimal adverse effects; however, hypersensitivity reactions may occur in rare cases. Lysoflam Forte should be administered under medical supervision, with dosage adjusted according to the severity of the condition and patient response. It is contraindicated in patients with known hypersensitivity to proteolytic enzymes and should be used cautiously in individuals with bleeding disorders or on anticoagulant therapy. This tablet serves as an adjunct to conventional treatment modalities, enhancing recovery and improving patient outcomes in inflammatory and edematous conditions.